Nocturnal asthma

Current Opinion in Pulmonary Medicine

Volumn 13, Issue 1, 2007, Pages 49-55

  Shigemitsu, Hidenobu ^a   Afshar, Kamyar ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

2 receptor polymorphism; Airway inflammation; Chronobiology; Gastroesophageal reflux disease; Obstructive sleep apnea

Indexed keywords

ALLERGEN; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; ESOMEPRAZOLE; GLUCOCORTICOID RECEPTOR; LANSOPRAZOLE; LEUKOTRIENE; MELATONIN; NITRIC OXIDE; PLACEBO; PREDNISONE; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; TRIAMCINOLONE;

ALLELE; CHRONOBIOLOGY; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG DOSE COMPARISON; GASTROESOPHAGEAL REFLUX; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; NOCTURNAL ASTHMA; PATHOPHYSIOLOGY; PEAK EXPIRATORY FLOW; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; REVIEW; SCORING SYSTEM; SLEEP APNEA SYNDROME; SNORING; SYMPTOM;

ANTACIDS; ASTHMA; CIRCADIAN RHYTHM; CONTINUOUS POSITIVE AIRWAY PRESSURE; GASTROESOPHAGEAL REFLUX; HUMANS; POLYMORPHISM, GENETIC; PREVALENCE; RECEPTORS, ADRENERGIC, BETA-2; SLEEP APNEA, OBSTRUCTIVE;

EID: 33845405066     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328010a890     Document Type: Review

References (40)

1. National Asthma Education and prevention Program, Expert panel report 2: guidelines for the diagnosis and prevention of asthma. Publication No. 97-405. Bethesda, MD: National Institute of Health; April 1997.
2. Martin RJ, Cicutto LC, Ballard RD. Factors related to the nocturnal worsening of asthma. Am Rev Respir Dis 1990; 141:33-38.
3. Turner-Warwick M. Epidemiology of nocturnal asthma. Am J Med 1988;85:6-8.
4. Raherison C, Abouelfath A, Le Gros V, et al. Underdiagnosis of nocturnal asthma in general practice. J Asthma 2006; 43:199-202. A large cross-sectional survey evaluating the prevalence and underdiagnosis of nocturnal asthma.
5. Kraft M, Djukanovic R, Wilson S, et al. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996; 154:1505-1510.
6. Kraft M, Martin RJ, Wilson S, et al. Lymphocyte and eosinophil influx into alveolar tissue in noctural asthma. Am J Respir Crit Care Med 1999; 159:228-234.
7. Ballard RD, Irvin CG, Martin RJ, et al. Influence of sleep on lung volume in asthmatic patients and normal subjects. J Appl Physiol 1990; 68:2034-2041.
8. Irvin CG, Pak J, Martin RJ. Airway-parenchyma uncoupling in nocturnal asthma. Am J Respir Crit Care Med 2000; 161:50-56.
9. Szefler SJ, Ando R, Cicutto LC, et al. Plasma histamine, epinephrine, cortisol, and leukocyte beta adrenergic receptors in nocturnal asthma. Clin Pharmacol Ther 1991; 49:59-68.
10. Turki J, Pak J, Green SA, et al. Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnoctural asthma. Evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest 1995; 95:1635-1641.
11. Yin K, Zhang X, Qiu Y. Association between beta2-adrenergic receptor genetic polymorphism and nocturnal asthmatic patients of Chinese Han nationality. Respiration 2006; 73:464-467. This study examined the prevalence of the Gly16 allele in nocturnal asthmatic patients.
12. Ramsay CE, Hayden CM, Tiller KJ, et al. Polymorphisms in the beta2-adrenoreceptor gene are associated with decreased airway responsiveness. Clin Exp Allergy 1999; 29:1195-1203.
13. Migita O, Noguchi E, Jian Z, et al. ADRB2 polymorphism and asthma susceptibility: transmission disequilibrium test and meta analysis. Int Arch Allergy Immunol 2004; 134:150-157.
14. Contopoulos-Ioannidis DG, Manoli EN, Ioannidis JP. Meta-analysis of the association of beta2-adrenergic receptor polymorphisms with asthma phenotypes. J Allergy Clin Immunol 2005; 115:963-972.
15. Thakkinstian A, McEvoy M, Minelli C, et al. Systematic review and meta-analysis of the association between beta2-adrenoreceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 2005; 162:201-211. This meta-analysis systematically investigated the Arg/Gly16 and Gln/Glu27 polymorphisms in relation to asthma susceptibility.
16. Kraft M, Vianna E, Martin RJ, et al. Nocturnal asthma is associated with reduced glucocorticoid receptor binding affinity and decreased steroid responsiveness at night. J Allergy Clin Immunol 1999; 103:66-71.
17. Kraft M, Hamid Q, Chrousos GP, et al. Decreased steroid responsiveness at night in nocturnal asthma: is the macrophage responsible? Am J Respir Crit Care Med 2001; 163:1219-1225.
18. Bellia V, Bonanno A, Cibella F, et al. Urinary luekotriene E4 in the assessment of nocturnal asthma. J Allergy Clin Immunol 1996; 97:735-741.
19. Kurokawa K, Tanaka H, Tanaka S, et al. Circadian characteristics of urinary leukotriene E4 in healthy subjects and nocturnal asthmatic patients. Chest 2001; 120:1822-1828.
20. Sutherland ER, Martin RJ, Ellison MC, et al. Immunomodulatory effects of melatonin in asthma. Am J Respir Crit Care Med 2002; 166:1055-1061.
21. Sutherland ER, Ellison MC, Kraft M, et al. Elevated serum melatonin is associated with the nocturnal worsening of asthma. J Allergy Clin Immunol 2003; 112:513-517.
22. ten Hacken NH, van der Vaart H, van der mark TW, et al. Exhaled nitric oxide is higher both at day and night in subjects with nocturnal asthma. Am J Respir Crit Care Med 1998; 158:902-907.
23. Georges G, Bartelson BB, Martin RJ, et al. Circadian variation in exhaled nitric oxide in nocturnal asthma. J Asthma 1999; 36:467-473.
24. Tan WC, Martin RJ, Pandey R, et al. Effects of spontaneous and simulated gastroespohageal reflux on sleeping asthmatics. Am Rev Respir Dis 1990; 141:1394-1399.
25. Gislason T, Janson C, Vermeire P, et al. Respiratory symptoms and nocturnal gastroesophageal reflux: a population-based survey of young adults in three European countries. Chest 2002; 121:158-163.
26. Chan CS, Woolcock AJ, Sullivan CE. Nocturnal asthma: role of snoring and obstructive sleep apnea. Am Rev Respir Dis 1988; 137:1502-1504.
27. Bohadana AB, Hannhart B, Teculescu DB. Nocturnal worsening of asthma and sleep-disorder breathing. J Asthma 2002; 39:85-100.
28. Ciftci TU, Ciftci B, Guven SF, et al. Effect of nasal continuous positive airway pressure in uncontrolled nocturnal asthmatic patients with obstructive sleep apnea syndrome. Respir Med 2005; 99:529-534. This study demonstrated OSA to be prevalent innocturnal asthmatic patients, and the treatment effects of nasal CPAP only improved asthma nighttime symptom scores.
29. Hakala K, Stenius-Aarniala B, Sovijarvi A. Effects of weight loss on peak flow variability, airway obstruction, and lung volumes in obese patients with asthma. Chest 2000; 118:1315-1321.
30. Pincus DJ, Szefler SJ, Ackerson LM, et al. Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. J Allergy Clin Immunol 1995; 95:1172-1178.
31. Pincus DJ, Humeston TR, Martin RJ. Further studies on chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. J Allergy Clin Immunol 1997; 100:771-774.
32. Beam WR, Weiner DE, Martin RJ. Timing of prednisone and alterations of airways inflammation in nocturnal asthma. Am Rev Respir Dis 1992; 146:1524-1530.
33. Lockey RF, DuBuske LM, Friedman B, et al. Nocturnal asthma: effect of salmeterol on quality of life and clinical outcomes. Chest 1999; 115:666-673.
34. Shah L, Wilson AJ, Gibson PG, et al. Long acting beta-agonists versus theophylline for maintenance treatment of asthma. Cochrane Database Syst Rev 2003; 3:CD001281.
35. Hendeles L, Beaty R, Ahrens R, et al. Response to inhaled albuterol during nocturnal asthma. J Allergy Clin Immunol 2004; 113:1058-1062.
36. Wenzel SE, Tradeau JB, Kaminsky DA, et al. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am J Respir Crit Care Med 1995; 152:897-905.
37. Martin RJ, Cicutto LC, Ballard RD, et al. Circadian variation in theophylline concentrations and the treatment of nocturnal asthma. Am Rev Respir Dis 1989; 139:475-478.
38. Gibson PG, Henry RL, Coughlan JL. Gastro-oesophageal reflux treatment for asthma in adults and children. Cochrane Database Syst Rev 2003; 2:CD001496.
39. Littner MR, Leung FW, Ballard ED II. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbation, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest 2005; 128:1128-1135. This randomized controlled trial demonstrated that lansoprazole was associated with less asthma exacerbation but did not improve lung functions.
40. Kiljander TO, Harding SM, Field SK, et al. Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial. Am J Respir Crit Care Med 2006; 173:1091-1097. This randomized controlled trial demonstrated that esomeprazole improved the morning and evening PEFR in nocturnal asthmatic patients with GERD.